4.5 Article

Biodynamic imaging for phenotypic profiling of three-dimensional tissue culture

Journal

JOURNAL OF BIOMEDICAL OPTICS
Volume 22, Issue 1, Pages -

Publisher

SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
DOI: 10.1117/1.JBO.22.1.016007

Keywords

three-dimensional tissue growth; biodynamic imaging; digital holography; low-coherence interferometry; cellular dynamics; dynamic light scattering; speckle; biomedical imaging; drug development; drug discovery; pharmaceutical; biological relevance; high-content imaging; physiological effects of paclitaxel.

Funding

  1. NSF [1263753-CBET]
  2. NIH NIBIB [1RO1EB016582-02]
  3. Div Of Chem, Bioeng, Env, & Transp Sys
  4. Directorate For Engineering [1263753] Funding Source: National Science Foundation

Ask authors/readers for more resources

Three-dimensional (3-D) tissue culture represents a more biologically relevant environment for testing new drugs compared to conventional two-dimensional cancer cell culture models. Biodynamic imaging is a highcontent 3-D optical imaging technology based on low-coherence interferometry and digital holography that uses dynamic speckle as high-content image contrast to probe deep inside 3-D tissue. Speckle contrast is shown to be a scaling function of the acquisition time relative to the persistence time of intracellular transport and hence provides a measure of cellular activity. Cellular responses of 3-D multicellular spheroids to paclitaxel are compared among three different growth techniques: rotating bioreactor (BR), hanging-drop (HD), and nonadherent (U-bottom, UB) plate spheroids, compared with ex vivo living tissues. HD spheroids have the most homogeneous tissue, whereas BR spheroids display large sample-to-sample variability as well as spatial heterogeneity. The responses of BR-grown tumor spheroids to paclitaxel are more similar to those of ex vivo biopsies than the responses of spheroids grown using HD or plate methods. The rate of mitosis inhibition by application of taxol is measured through tissue dynamics spectroscopic imaging, demonstrating the ability to monitor antimitotic chemotherapy. These results illustrate the potential use of low-coherence digital holography for 3-D pharmaceutical screening applications. (C) 2017 Society of Photo-Optical Instrumentation Engineers (SPIE)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available